Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Tg Therapeutics (TGTX) Revenue (2016 - 2025)

Historic Revenue for Tg Therapeutics (TGTX) over the last 10 years, with Q3 2025 value amounting to $161.7 million.

  • Tg Therapeutics' Revenue rose 9278.84% to $161.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $531.9 million, marking a year-over-year increase of 10087.54%. This contributed to the annual value of $329.0 million for FY2024, which is 4080.34% up from last year.
  • Per Tg Therapeutics' latest filing, its Revenue stood at $161.7 million for Q3 2025, which was up 9278.84% from $141.1 million recorded in Q2 2025.
  • In the past 5 years, Tg Therapeutics' Revenue ranged from a high of $165.8 million in Q3 2023 and a low of $80000.0 during Q4 2022
  • For the 5-year period, Tg Therapeutics' Revenue averaged around $52.4 million, with its median value being $16.1 million (2023).
  • Per our database at Business Quant, Tg Therapeutics' Revenue tumbled by 9655.32% in 2022 and then soared by 17629893.62% in 2023.
  • Quarter analysis of 5 years shows Tg Therapeutics' Revenue stood at $2.3 million in 2021, then crashed by 96.55% to $80000.0 in 2022, then surged by 54863.75% to $44.0 million in 2023, then skyrocketed by 146.04% to $108.2 million in 2024, then soared by 49.47% to $161.7 million in 2025.
  • Its last three reported values are $161.7 million in Q3 2025, $141.1 million for Q2 2025, and $120.9 million during Q1 2025.